Olmesartan Medoxomil And Hydrochlorothiazide Tablet, Film Coated
Product Images NDC 72603-290

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Olmesartan Medoxomil And Hydrochlorothiazide (NDC 72603-290). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rxllc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

222 (Olmesartan Hctz 20 12 5mg 30s)

This is a medication with NDC code 72603-290-01 containing Olmesartan medoxomil 20 mg and Hydrochlorothiazide 12.5 mg per tablet. It is important to refer to the prescribing information for the usual dosage and administration instructions. The tablets should be stored at 20° to 25°C (68° to 77°F) with excursions permitted to 15° to 30°C (59° to 86°F). This product is manufactured for Northstar Rx LLC by Macleods Pharmaceuticals Ltd. and is a product of India.*

FDA Label Image

333 (Olmesartan Hctz 20 12 5mg 90s)

This text provides information about a medication with National Drug Code (NDC) 72603-290-02. Each tablet contains Olmesartan medoxomil (20 mg) and Hydrochlorothiazide (12.5 mg). The dosage details are available in the prescribing information. The storage conditions for Hydrochlorothiazide are specified as storing at 20° to 25°C (68° to 77°F), with excursions allowed to 15° to 30°C (59° to 86°F). The tablets are manufactured in India by Northstar Rx LLC and Macleods Pharmaceuticals Ltd.*

FDA Label Image

444 (Olmesartan Hctz 40 12 5mg 30s)

This is information for Olmesartan Medoxomil and Hydrochlorothiazide tablets, with a dosage of 40 mg/12.5 mg. Each tablet contains Olmesartan Medoxomil 40mg and Hydrochlorothiazide 12.5mg. It is advised to store these tablets at a temperature between 20°C to 25°C (68°F to 77°F). Make sure to read the Prescribing Information for Dosage and Administration guidelines. The tablets are manufactured by Macleods Pharmaceuticals Ltd. in Daman, India.*

FDA Label Image

555 (Olmesartan Hctz 40 12 5mg 90s)

This is a description for a medication with the NDC number 72603-291-02. The medication is a combination of Olmesartan Medoxomil and Hydrochlorothiazide in tablet form, with each tablet containing 40 mg of Olmesartan Medoxomil and 12.5 mg of Hydrochlorothiazide. The packaging contains 90 tablets and provides information on storage conditions and dosage. The manufacturer is Northstar Rx LLC, and the medication is manufactured by Macleods Pharmaceuticals Ltd in India.*

FDA Label Image

666 (Olmesartan Hctz 40 25mg 30s)

Each tablet contains a combination of Olmesartan medoxomil (40 mg) and Hydrochlorothiazide (25 mg). This medication is commonly used for hypertension. It is advised to store the tablets between 20°C to 25°C (68°F to 77°F). Refer to the prescribing information for the recommended dosage. The product is manufactured by Macleods Pharmaceuticals Ltd. in India for Northstar Rx LLC.*

FDA Label Image

777 (Olmesartan Hctz 40 25mg 90s)

This is a description of Olmesartan Medoxomil and Hydrochlorothiazide tablets containing 40 mg/25 mg strength with 90 tablets per bottle. Each tablet contains Olmesartan Medoxomil 40 mg and Hydrochlorothiazide 25 mg. The usual dosage information is provided in the prescribing information. The tablets should be stored at 20° to 25°C with excursions permitted to 15° to 30°C (68° to 77°F). The packaging has an OPZ area of 49 x 15 mm, and the expiration date is 11/2024. The tablets are manufactured by Macleods Pharmaceuticals Ltd. in India for Northstar Rx LLC.*

FDA Label Image

505 (Olmesartan Hctz Structure)

FDA Label Image

505 (Olmesartan Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.